We are live on ! Find out more
CLDX icon

Celldex Therapeutics
CLDX

174 hedge funds and large institutions have $1.86B invested in Celldex Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 48 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $24.9M | Put options by funds: $17.1M

38% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 48

2.75% more ownership

Funds ownership: 108.33% → 111.07% (+2.7%)

6% less first-time investments, than exits

New positions opened: 34 | Existing positions closed: 36

1% less funds holding

Funds holding: 176 → 174 (-2)

24% less capital invested

Capital invested by funds: $2.44B → $1.86B (-$579M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
174
Holders Change
-2
Holders Change %
-1.14%
% of All Funds
2.29%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
34
Increased
66
Reduced
48
Closed
36
Calls
$24.9M
Puts
$17.1M
Net Calls
+$7.83M
Net Calls Change
-$17.5M

Top Buyers

1
JFG
Jefferies Financial Group
New York
+$64.4M
2
KCM
Kynam Capital Management
New Jersey
+$43.6M
3
DTC
Deep Track Capital
Connecticut
+$41.8M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$25.7M
5
Morgan Stanley
Morgan Stanley
New York
+$24.7M

Top Sellers

1
CC
Commodore Capital
New York
-$55M
2
Jennison Associates
Jennison Associates
New York
-$45M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.7M
4
PCH
Polar Capital Holdings
United Kingdom
-$31.4M
5
LGM
Logos Global Management
California
-$30.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
State of Wisconsin Investment Board
76
State of Wisconsin Investment Board
Wisconsin
$1.02M -$28.4K -1,047 -3%
MIM
77
MetLife Investment Management
New Jersey
$1M +$62.2K +2,288 +6%
AI
78
Atom Investors
Texas
$991K +$1.07M +39,203 New
Canada Pension Plan Investment Board
79
Canada Pension Plan Investment Board
Ontario, Canada
$935K -$734K -27,000 -42%
Capital Fund Management (CFM)
80
Capital Fund Management (CFM)
France
$893K -$14.9K -548 -2%
TC
81
TwinBeech Capital
New York
$873K -$2.88M -105,944 -75%
IIM
82
INTECH Investment Management
Florida
$858K +$226K +8,303 +32%
Two Sigma Investments
83
Two Sigma Investments
New York
$835K +$897K +33,025 New
Tudor Investment Corp
84
Tudor Investment Corp
Connecticut
$822K +$884K +32,545 New
Wells Fargo
85
Wells Fargo
California
$821K +$274K +10,087 +45%
CF
86
Corebridge Financial
Texas
$812K -$65.9K -2,424 -7%
TE
87
Tema ETFs
New York
$745K +$801K +29,480 New
PA
88
Profund Advisors
Maryland
$744K +$295K +10,873 +59%
VFA
89
Values First Advisors
Tennessee
$733K +$131K +4,837 +20%
Janus Henderson Group
90
Janus Henderson Group
United Kingdom
$647K – – –
SG Americas Securities
91
SG Americas Securities
New York
$639K +$135K +4,967 +24%
ACH
92
ArrowMark Colorado Holdings
Colorado
$632K – – –
DekaBank Deutsche Girozentrale
93
DekaBank Deutsche Girozentrale
Germany
$628K – – –
GC
94
Guggenheim Capital
Illinois
$601K +$647K +23,797 New
BPC
95
Bryce Point Capital
New York
$601K +$646K +23,790 New
Ensign Peak Advisors
96
Ensign Peak Advisors
Utah
$592K – – –
FRM
97
Fox Run Management
Connecticut
$589K +$379K +13,966 +150%
New York State Common Retirement Fund
98
New York State Common Retirement Fund
New York
$562K – – –
AQR Capital Management
99
AQR Capital Management
Connecticut
$549K -$98.3K -3,619 -14%
Handelsbanken Fonder
100
Handelsbanken Fonder
Sweden
$533K +$198K +7,300 +53%
2 3
4
5 6

CLDX Hedge Fund Activity: Q4 2024 in Review

174 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Celldex Therapeutics (CLDX) for Q4 2024, worth a combined $1.86B — down 24% from $2.44B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of CLDX and 34 opened new positions — a net loss of 2 holders — while 48 trimmed existing stakes and 66 added.

The largest buyer was Jefferies Financial Group, adding an estimated $64.4M. The largest seller was Commodore Capital, exiting entirely with an estimated $55M sold.

  • 174 institutional investors held Celldex Therapeutics (CLDX) as of Q4 2024, down from 176 in Q3 2024.
  • Funds reported $1.86B of Celldex Therapeutics stock for Q4 2024, down 24% quarter-over-quarter.
  • 34 funds opened new Celldex Therapeutics positions in Q4 2024 and 36 closed out, a net change of -2 holders.
  • The largest Celldex Therapeutics buyer in Q4 2024 was Jefferies Financial Group, an estimated $64.4M added.
  • The largest Celldex Therapeutics seller in Q4 2024 was Commodore Capital, an estimated $55M sold.

Based on aggregated 13F filings for Q4 2024.